Spinifex Pharmaceuticals
AcquiredAustralia · $66.5M raised
- Business Model
- B2B
- Total Funding
- $66.5M
- Last Round
- $45.0M Series CApr 2014
- Rounds
- 3
About
Development-stage biotech focused on peripheral treatments for chronic pain; acquired by Novartis for up to AU$1B.
Summary
Spinifex Pharmaceuticals is a Biotech company based in Australia. It has raised $66.5M in total across 3 rounds, most recently a $45.0M Series C round in Apr 2014. Investors include Novo A/S, Uniseed and Brandon Capital Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2015
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company